WallStSmart

Alcon AG (ALC)vsKestra Medical Technologies, Ltd. Common Stock (KMTS)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Alcon AG generates 10077% more annual revenue ($10.86B vs $106.73M). ALC leads profitability with a 5.9% profit margin vs -140.4%. ALC earns a higher WallStSmart Score of 51/100 (C-).

ALC

Buy

51

out of 100

Grade: C-

Growth: 4.7Profit: 4.5Value: 4.0Quality: 6.8
Piotroski: 3/9

KMTS

Avoid

28

out of 100

Grade: F

Growth: 8.0Profit: 2.0Value: 5.0Quality: 6.5
Piotroski: 4/9Altman Z: -1.47
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ALCSignificantly Overvalued (-22.8%)

Margin of Safety

-22.8%

Fair Value

$64.64

Current Price

$66.18

$1.54 premium

UndervaluedFair: $64.64Overvalued

Intrinsic value data unavailable for KMTS.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ALC2 strengths · Avg: 9.5/10
Price/BookValuation
1.5x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.259/10

Conservative balance sheet, low leverage

KMTS1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
59.9%10/10

Revenue surging 59.9% year-over-year

Areas to Watch

ALC4 concerns · Avg: 2.8/10
Return on EquityProfitability
3.0%3/10

ROE of 3.0% — below average capital efficiency

Profit MarginProfitability
5.9%3/10

5.9% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

P/E RatioValuation
48.8x2/10

Premium valuation, high expectations priced in

KMTS4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.63B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-50.3%2/10

ROE of -50.3% — below average capital efficiency

Free Cash FlowQuality
$-40.63M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : ALC

The strongest argument for ALC centers on Price/Book, Debt/Equity. PEG of 1.16 suggests the stock is reasonably priced for its growth.

Bull Case : KMTS

The strongest argument for KMTS centers on Revenue Growth. Revenue growth of 59.9% demonstrates continued momentum.

Bear Case : ALC

The primary concerns for ALC are Return on Equity, Profit Margin, Piotroski F-Score. A P/E of 48.8x leaves little room for execution misses.

Bear Case : KMTS

The primary concerns for KMTS are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

ALC profiles as a value stock while KMTS is a hypergrowth play — different risk/reward profiles.

KMTS is growing revenue faster at 59.9% — sustainability is the question.

ALC generates stronger free cash flow (414M), providing more financial flexibility.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ALC scores higher overall (51/100 vs 28/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alcon AG

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.

Visit Website →

Kestra Medical Technologies, Ltd. Common Stock

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Kestra Medical Technologies, Ltd. is a wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington.

Visit Website →

Want to dig deeper into these stocks?